Marwa El-Zeftawy

Dr. Marwa El-Zeftawy


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2021 in Molecules
Verified
Journal Article
Open access
PDF file
MBMahmoud Esmat Balbaa
Mahmoud Esmat Balbaa
MEMarwa El-Zeftawy
Marwa El-Zeftawy
SAShaymaa Abdulmalek
Shaymaa Abdulmalek
The study of diabetes mellitus (DM) patterns illustrates increasingly important facts. Most importantly, they include oxidative stress, inflammation, and cellular death. Up to now, there is a shortage of drug therapies for DM, and the discovery and the development of novel therapeutics for this disease are crucial. Medicinal plants are being used more and more as an alternative and natural cure for the disease. Consequently, the objective of this review was to examine the latest results on the effectiveness and protection of natural plants in the management of DM as adjuvant drugs for diabetes and its complex concomitant diseases.

11 September 2019 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
MEMarwa El-Zeftawy
Marwa El-Zeftawy
Doaa A GhareebDoaa A Ghareeb
Doaa A Ghareeb
Eman ElbealyEman Elbealy
Eman Elbealy
RSRasha Saad
Rasha Saad
SMSalma Mahmoud
Salma Mahmoud
MEMohamed El‐Sayed
Mohamed El‐Sayed

9 May 2020 in Reproduction in Domestic Animals
Verified
Journal Article
Closed access
PDF file
MEMarwa El-Zeftawy
Marwa El-Zeftawy
GMGamal B. Mahmoud
Gamal B. Mahmoud
MHMervat Hassan
Mervat Hassan

27 July 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MEMarwa El-Zeftawy
Marwa El-Zeftawy
Doaa A GhareebDoaa A Ghareeb
Doaa A Ghareeb
Inflammation is interfaced with various metabolic disorders. Ceratonia siliqua (CS) has a higher pharmaceutical purpose. The research aimed to investigate the biofunction of CS pulp aqueous extract (CS-PAE) with an emphasis on its integrated computational approaches as opposed to different specific receptors contributing to inflammation. The extract was assessed for its chemical and phenolic components via GC–MS, LC–MS, HPLC, and total phenolic and flavonoid content. In vitro, bioactivities and molecular docking were analyzed. Findings indicate that CS-PAE demonstrated higher scavenging activities of nitric oxide, 1,1-diphenyl-2-picrylhydrazyl radical, superoxide anion, hydrogen peroxide, and anti-lipid peroxidation (IC50 values were 5.29, 3.04, 0.63, 7.35 and 9.6 mg/dl, respectively). The extract revealed potent inhibition of RBCs hemolysis, acetylcholine esterase, monoamine oxidase-B, and α-glucosidase enzymes (IC50 was 13.44, 9.31, 2.45, and 1.5 mg/dl, respectively). The extract exhibited a cytotoxic effect against prostate cancer Pc3, liver cancer HepG2, colon cancer Caco2, and lung cancer A549 cell lines. Moreover, CS-PAE owned higher antiviral activity against virus A and some bacteria. When contrasting data from molecular docking, it was reported that both apigenin-7-glucoside and rutin in CS-PAE have a good affinity toward the Keap-1/Nrf2/ NF-ĸB pathway. In conclusion, CS-PAE showed promise in therapeutic activity in metabolic conditions.

4 June 2020 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
MEMarwa El-Zeftawy
Marwa El-Zeftawy
SASamar Abd‐El Mohsen Ali
Samar Abd‐El Mohsen Ali
SSSally Salah
Sally Salah
HHHani S. Hafez
Hani S. Hafez
The present study was to investigate the effective role of renewable sources of Ca+2 from eggshell (ES) with different doses to restrict obesity disorders. Rats were classified as follows, G1: normal diet for 26 weeks; G2: high‐fat diet (HFD) for 26 weeks; G3, G4, and G5 were supplemented with HFD for 16 weeks and treated with 7.2 g Ca+2 ES/Kg rat chow, 18 g Ca+2 ES/Kg rat chow, and 2% diet containing fat (DCF), respectively, for the remaining 10 weeks. Results revealed a significant effect of the low dose of Ca+2 supplement in form of ES than high dose and 2% DCF; on basis of anthropometric parameters, lipid, leptin, adiponectin, thyroid hormones, Ca+2, 25‐hydroxyl vitamin‐D, and oxidative and inflammatory parameters were regulated. Results were confirmed with the histopathological study. Therefore, it was concluded that Ca+2 supplementation can be used as a beneficial source for obesity management with anticholesterol actions. Practical applications Obesity represented public health hazards. The eggshell is one of the waste products that contain a high percentage of Ca+2. The current data exposed using a low dose of ES as a new source of Ca+2 supplement for treatment of HFD rats leads to significant enhancement of lipid profiles, liver enzymes, kidney functions, leptin, adiponectin, Ca+2, 25(OH)‐D, TSH, fT4, and PTH levels. Also, there was a reduction in weight gain, Bwt, BMI, BG, insulin, and HOMA‐IR. Moreover, the oxidant‐pro‐oxidant system was improved in both hepatic and adipose tissues where NO and TBARS concentrations were diminished, and SOD specific activity was elevated. Additionally, TNF‐α and ADAM17 expression were downregulated. Hence, it was concluded that there was good evidence that diets supplemented with ES were associated with the reduction of obesity complications especially regulating fat processing and storage in the body.

11 August 2022 in New Valley Veterinary Journal
Verified
Journal Article
Closed access
PDF file
HMHasnaa Mansour
Hasnaa Mansour
MEMarwa El-Zeftawy
Marwa El-Zeftawy
MAMohamed Aboubakr
Mohamed Aboubakr
RERabab Elzoghby
Rabab Elzoghby
The liver is a vital organ that performs the majority of the body's metabolic and detoxifying functions. There are various exogenous and endogenous factors that might cause liver issues. Carbon tetrachloride (CCL4) is non-inflammable colorless organic compound and employed in a variety of industrial fields. N-acetylcysteine (NAC) is one of the prospective pharmaceutical candidates possesses multiple clinical applications. The purpose of this study is to determine whether or not NAC has a protective effect in cases of liver injury. Thirty male albino rats were involved in the study, which lasted one month. They were categorized into three groups: control, liver injury group (0.5 ml/kg rat body weight (Bwt) CCL4 administered orally twice a week), and protective group (150 mg/kg Bwt NAC supplied orally). Serum lipid and protein profiles and liver enzymes activities were evaluated. Antioxidant, oxidative stress and anti-inflammatory parameters were also assessed. Additionally, hepatic tissue was subjected to a histopathological investigation. The biochemical and histopathological results revealed dramatic improvement of studied parameters in NAC protective group comparing to liver injury one. Hence, we can conclude that, NAC shown a great potential in attenuating liver injury induced by CCL4 via refinement tumor necrosis factor-alpha, interleukin-6 and reduced glutathione pathway.